US 11,872,217 B2
Indanes as PD-L1 inhibitors
Viengkham Malathong, Mountain View, CA (US); Venkat Reddy Mali, Cupertino, CA (US); Darren J. McMurtrie, Sunnyvale, CA (US); Sreenivas Punna, Sunnyvale, CA (US); Howard S. Roth, Sunnyvale, CA (US); Rajinder Singh, Belmont, CA (US); Ju Yang, Palo Alto, CA (US); and Penglie Zhang, Foster City, CA (US)
Assigned to CHEMOCENTRYX, INC., Thousand Oaks, CA (US)
Filed by CHEMOCENTRYX, INC., Mountain View, CA (US)
Filed on Jul. 9, 2020, as Appl. No. 16/924,385.
Claims priority of provisional application 62/872,541, filed on Jul. 10, 2019.
Prior Publication US 2021/0008049 A1, Jan. 14, 2021
Int. Cl. A61K 31/444 (2006.01); C07D 401/12 (2006.01); C07C 229/36 (2006.01); C07C 219/28 (2006.01); C07C 309/24 (2006.01); C07D 207/267 (2006.01); A61K 31/397 (2006.01); A61K 31/4545 (2006.01); A61K 31/197 (2006.01); A61K 31/137 (2006.01); A61K 31/4015 (2006.01); A61K 31/4188 (2006.01); C07D 487/10 (2006.01)
CPC A61K 31/444 (2013.01) [A61K 31/137 (2013.01); A61K 31/197 (2013.01); A61K 31/397 (2013.01); A61K 31/4015 (2013.01); A61K 31/4188 (2013.01); A61K 31/4545 (2013.01); C07C 219/28 (2013.01); C07C 229/36 (2013.01); C07C 309/24 (2013.01); C07D 207/267 (2013.01); C07D 401/12 (2013.01); C07D 487/10 (2013.01)] 24 Claims
 
1. A compound selected from the group consisting of

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.